X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
1,4-dihydropyridine (1) 1
1,4-dihydropyridines (1) 1
1,4‐dihydropyridines (1) 1
acetylcholinesterase - metabolism (1) 1
ache peripheral anionic site (1) 1
alzheimer disease - drug therapy (1) 1
alzheimer disease - enzymology (1) 1
alzheimer disease - pathology (1) 1
alzheimer's disease (1) 1
alzheimers disease (1) 1
amyloid beta-peptides - metabolism (1) 1
amyloid precursor protein (1) 1
amyloid precursor protein secretases - antagonists & inhibitors (1) 1
amyloid precursor protein secretases - metabolism (1) 1
amyloid-ss antiaggregating agents (1) 1
amyloid-β antiaggregating agents (1) 1
amyloid–β antiaggregating agents (1) 1
anti-inflammatory drugs (1) 1
antioxidant drugs (1) 1
antioxidants (1) 1
anti‐inflammatory drugs (1) 1
bace-1 inhibitors (1) 1
bace‐1 inhibitors (1) 1
binding sites (1) 1
butyrylcholinesterase - metabolism (1) 1
ca2+ dyshomeostasis (1) 1
ca2+ overload (1) 1
calcium channels (1) 1
calcium channels - metabolism (1) 1
cancer (1) 1
care and treatment (1) 1
cdk5 inhibitors (1) 1
central-nervous-system (1) 1
chemistry, medicinal (1) 1
ck-1 inhibitors (1) 1
ck‐1 inhibitors (1) 1
development and progression (1) 1
disease progression (1) 1
drug therapy (1) 1
dual ache inhibitors (1) 1
dyshomeostasis (1) 1
enzyme inhibitors (1) 1
enzyme inhibitors - pharmacology (1) 1
enzyme inhibitors - therapeutic use (1) 1
erk2-inhibitors (1) 1
erk2‐inhibitors (1) 1
glutamate (1) 1
glycogen (1) 1
gsk-3 ss inhibitors (1) 1
gsk-3β inhibitors (1) 1
gsk‐3β inhibitors (1) 1
herpes-simplex-virus (1) 1
humans (1) 1
index medicus (1) 1
ligands (1) 1
m1 muscarinic agonists (1) 1
medical research (1) 1
metal chelators (1) 1
methyl aspartate (1) 1
molecular modeling investigations (1) 1
multiactive compounds (1) 1
multitarget drugs (1) 1
neuroprotection (1) 1
nmda receptor antagonist (1) 1
nsaids (1) 1
overload (1) 1
oxidative stress (1) 1
peripheral anionic site (1) 1
pharmacology & pharmacy (1) 1
potent acetylcholinesterase inhibitors (1) 1
proteins (1) 1
receptors, n-methyl-d-aspartate (1) 1
rodents (1) 1
surface active agents (1) 1
synthesis (1) 1
tacrine-dihydropyridine hybrids (1) 1
target marketing (1) 1
tau proteins - metabolism (1) 1
tyrosine kinase inhibitor (1) 1
voltage-dependent calcium channels (1) 1
voltage‐dependent calcium channels (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Medicinal Research Reviews, ISSN 0198-6325, 01/2013, Volume 33, Issue 1, pp. 139 - 189
With 27 million cases worldwide documented in 2006, Alzheimer's disease (AD) constitutes an overwhelming health, social, economic, and political problem to... 
antioxidant drugs | CDK5 inhibitors | anti‐inflammatory drugs | AChE peripheral anionic site | CK‐1 inhibitors | ERK2‐inhibitors | Ca2+ dyshomeostasis | BACE‐1 inhibitors | amyloid–β antiaggregating agents | NSAIDs | neuroprotection | multitarget drugs | GSK‐3β inhibitors | dual AChE inhibitors | metal chelators | Alzheimer's disease | Ca2+ overload | oxidative stress | multiactive compounds | 1,4‐dihydropyridines | voltage‐dependent calcium channels | Neuroprotection | Oxidative stress | Dual AChE inhibitors | Anti-inflammatory drugs | GSK-3β inhibitors | Antioxidant drugs | overload | Metal chelators | Multitarget drugs | Voltage-dependent calcium channels | CK-1 inhibitors | BACE-1 inhibitors | dyshomeostasis | 1,4-dihydropyridines | ERK2-inhibitors | Multiactive compounds | Amyloid-β antiaggregating agents | GSK-3 ss inhibitors | anti-inflammatory drugs | voltage-dependent calcium channels | TYROSINE KINASE INHIBITOR | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | POTENT ACETYLCHOLINESTERASE INHIBITORS | amyloid-ss antiaggregating agents | M1 MUSCARINIC AGONISTS | CHEMISTRY, MEDICINAL | AMYLOID PRECURSOR PROTEIN | MOLECULAR MODELING INVESTIGATIONS | HERPES-SIMPLEX-VIRUS | TACRINE-DIHYDROPYRIDINE HYBRIDS | PERIPHERAL ANIONIC SITE | NMDA RECEPTOR ANTAGONIST | Calcium Channels - metabolism | Humans | Enzyme Inhibitors - pharmacology | Alzheimer Disease - drug therapy | tau Proteins - metabolism | Receptors, N-Methyl-D-Aspartate | Alzheimer Disease - enzymology | Enzyme Inhibitors - therapeutic use | Disease Progression | Alzheimer Disease - pathology | Amyloid Precursor Protein Secretases - metabolism | Butyrylcholinesterase - metabolism | Amyloid beta-Peptides - metabolism | Ligands | Amyloid Precursor Protein Secretases - antagonists & inhibitors | Binding Sites | Acetylcholinesterase - metabolism | Care and treatment | Calcium channels | Glycogen | Development and progression | Glutamate | Target marketing | Antioxidants | Methyl aspartate | Enzyme inhibitors | Synthesis | Surface active agents | Drug therapy | Cancer
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.